- Research works
- 66 ▼ 100% vs 2018-21
- Citations
- 2k 30.2 per fractional work
- Top-10% rate
- 21.1% all institutions 10.0%
- Open access
- 43% world 40%
- International
- 12% world 18%
Not ranked overall: Morphotek (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Morphotek (United States) work in?
In all years, 56% of research at Morphotek (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (8%). It does 2.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 9 fields, with their numbers
- Health Sciences3756.0%
- Medicine3756.0%
- Life Sciences2841.6%
- Physical Sciences22.4%
- Chemistry11.0%
- Engineering00.8%
- Materials Science00.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Morphotek (United States)?
Ranked on the quality score, Daniel John O'Shannessy, Nicholas C. Nicolaides and Philip M. Sass lead among researchers whose main affiliation is Morphotek (United States).
- 1
Daniel John O'Shannessy
United States · #178,904 worldwide 5.7k citations · 106 works
- 2
Nicholas C. Nicolaides
United States · #206,173 worldwide 17k citations · 169 works
- 3
Philip M. Sass
United States · #593,126 worldwide 3.5k citations · 41 works
- 4
Martin D. Phillips
United States · #825,027 worldwide 1.3k citations · 21 works
- 5
Elizabeth Brooke Somers
United States · #1,053,487 worldwide 1.7k citations · 39 works
- 6
Qimin Chao
United States · #1,192,531 worldwide 4.1k citations · 18 works
- 7
Luigi Grasso
United States · #1,275,531 worldwide 2.8k citations · 122 works
- 8
Susan C. Weil
United States · #1,374,582 worldwide 1.9k citations · 61 works
- 9
Wolfgang Ebel
United States · #1,581,623 worldwide 894 citations · 18 works
- 10
Charles Schweizer
United States · #1,597,315 worldwide 925 citations · 30 works
Which keywords describe research at Morphotek (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cancer, Antibody Engineering, Fc Receptors, Immunotherapy and Angiogenesis.
- p53
- Immune System
- Cytoreductive Surgery
- Tumor Microenvironment
- Fibrosis
- Apoptosis
- Folate
- Endothelial Dysfunction
- Clinical Trials
- Targeted Therapy
- HER2
- Arginine Deprivation
- Cancer Therapy
- Tumor Targeting
- Inflammation
- Breast Cancer
- Angiogenesis
- Fc Receptors
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Cancer
- Immunotherapy
- Chemotherapy
- Tumor Regression
- Monoclonal Antibody
- Gene Therapy
- Metastasis
- Bacterial Therapy
- Trastuzumab
- Tumor Suppression
- Autoimmunity
- Regulation
- Homocysteine
- Biopharmaceuticals
- PET Imaging
- Cell Cycle
- Immune Regulation
- Therapeutics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation10▲ 72×3 topics
- Monoclonal Antibodies9▲ 95×3 topics
- Therapeutic Antibodies8▲ 101×2 topics
- Antibody Engineering8▲ 113×1 topic
- Cancer8▲ 8.1×13 topics
- Fc Receptors8▲ 113×1 topic
- Immunotherapy7▲ 16×7 topics
- Angiogenesis6▲ 24×7 topics
- Chemotherapy6▲ 13×7 topics
- Breast Cancer5▲ 27×5 topics
- Tumor Regression5▲ 86×2 topics
- Inflammation5▲ 3.1×12 topics
- Monoclonal Antibody5▲ 99×2 topics
- Tumor Targeting5▲ 53×3 topics
- Gene Therapy4▲ 25×2 topics
- Cancer Therapy4▲ 10×8 topics
- Metastasis4▲ 19×6 topics
- Arginine Deprivation4▲ 141×1 topic
- Bacterial Therapy4▲ 141×1 topic
- HER24▲ 182×1 topic
- Trastuzumab4▲ 129×1 topic
- Targeted Therapy3▲ 24×3 topics
- Tumor Suppression3▲ 45×2 topics
- Clinical Trials3▲ 7.4×3 topics
- Autoimmunity3▲ 20×2 topics
- Endothelial Dysfunction3▲ 15×2 topics
- Regulation3▲ 6.9×3 topics
- Folate3▲ 100×1 topic
- Homocysteine3▲ 100×1 topic
- Apoptosis2▲ 9.7×3 topics
- Biopharmaceuticals2▲ 56×3 topics
- Fibrosis2▲ 19×2 topics
- PET Imaging2▲ 17×4 topics
- Tumor Microenvironment2▲ 10×7 topics
- Cell Cycle2▲ 60×1 topic
- Cytoreductive Surgery2▲ 52×2 topics
- Immune Regulation2▲ 27×2 topics
- Immune System2▲ 11×2 topics
- Therapeutics2▲ 24×2 topics
- p532▲ 80×1 topic
Which research topics does Morphotek (United States) publish most on?
By volume: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, HER2/EGFR in Cancer Research and Folate and B Vitamins Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 8 works
- 2 Cancer Research and Treatments Biotechnology 4 works
- 3 HER2/EGFR in Cancer Research Oncology 4 works
- 4 Folate and B Vitamins Research Rheumatology 3 works
- 5 Cancer-related Molecular Pathways Oncology 2 works
- 6 Galectins and Cancer Biology Immunology 2 works
- 7 Glycosylation and Glycoproteins Research Molecular Biology 2 works
- 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 9 Cancer Cells and Metastasis Oncology 2 works
- 10 Angiogenesis and VEGF in Cancer Molecular Biology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Morphotek (United States)'s research output changed?
Output in 2022-2025 was 100% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Morphotek (United States) as a percentage of every work published that year, 0.00017% in 2018.
Fractional works of Morphotek (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Exton
- Brandywine Photonics (United States)
- Daniel H. Wagner Associates (United States)
- Melior Discovery (United States)
- Bentley Systems (United States)
- Absorption Systems (United States)
- West Pharmaceutical Services (United States)
- Immunome (United States)
- Netzsch (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Morphotek (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.